FindTrial
Sign In

Comparison of two different methods in treatment of cervical cancer

Comparison of Single and Energy Combination Volumetric Modulated ARC Therapy For Sparing Bone Marrow in Cervical Cancer.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/07/026521
Enrollment
10
Registered
2020-07-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Department of Radiotherapy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Cervical cancer plans

Exclusion criteria

Exclusion criteria: Cervical cancer plans not following bladder protocol

Design outcomes

Primary

MeasureTime frame
Conformity Index Homogeneity Index Maximum and Mean dose received by PTV Mean dose of bone marrow Maximum and mean dose to OARs Dose received by 40% of bone marrow (D40%) Dose received by 20% of bone marrow (D20%) Volumes of bone marrow receiving 10-50Gy Target volume receiving 95% of the prescribed dose (TV95% in %) Target volume receiving 107% of the prescribed dose (TV107% in %) Timepoint: 8 weeks—

Secondary

MeasureTime frame
NATimepoint: NA—

Countries

India

Contacts

Public ContactShambhavi C

MCHP Manipal

shambhavi.udupi@gmail.com9901437794

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026